Extrachromosomal DNA micronucleation constrains tumour fitness and improves patient survival
Authors
- L. Brückner
- R. Xu
- J. Tang
- A. Gnanasekar
- A. Herrmann
- I.T.L. Wong
- S. Zhang
- F. Tu
- M. Pilon
- A. Kukalev
- K. Pardon
- O. Sidorova
- J. Atta
- Q. Yu
- G. Montouri
- D. Pradella
- M. Ilić
- K. Suina
- M. Novais-Cruz
- S. Kaltenbach
- D. Treue
- M. Giurgiu-Kraljič
- S. Herzog
- A.S. Hollinger
- N. Wittstruck
- M. Fernandez
- N. Wolozyn
- F. Becker
- V.R. Louma
- X. Yan
- R. Schmargon
- J. Dörr
- D. Gamlin
- A. Lehmann
- D. Gürgen
- M. Richter
- F. Dubois
- F. Simeoni
- B.R. Pennycook
- A. Hamilton
- R.K. Lindemann
- C. Dawes
- G. Balmus
- B. Hero
- M. Fischer
- V. Bafna
- R. Verhaak
- G. Wahl
- Y. Liu
- R.P. Koche
- S. Papathanasiou
- R. Medema
- B. Spanjaard
- A. Ventura
- A. Pombo
- W. Huang
- M. Scheer
- B. Werner
- H.Y. Chang
- P.S. Mischel
- A.G. Henssen
Journal
- bioRxiv
Citation
- bioRxiv
Abstract
Extrachromosomal DNA (ecDNA) contributes to cancer genome instability by enabling high-copy oncogene amplification, intratumoural heterogeneity and rapid genetic change. Micronuclei (MN) are frequently observed in chromosomally unstable cancers, yet their origins and relevance in ecDNA-driven tumours remain incompletely understood. Here, we investigate the relationship between ecDNA segregation errors and MN formation. We find that ecDNA frequently localizes to MN and represents a prominent source of MN content in ecDNA-positive cancer cells. Mitotic clustering of oncogene-bearing ecDNAs is associated with asymmetric inheritance and mis-segregation into MN. Transfer of oncogenes from ecDNA into MN is accompanied by reduced transcriptional output. Single-MN sequencing shows that individual MN are enriched for ecDNA to a degree that exceeds expectations from stochastic mis-segregation and that in MN oncogenes originating from multiple distinct ecDNAs coalesce. Using live-cell imaging, we observe that cells inheriting ecDNA-positive MN show limited proliferative capacity and an increased likelihood of cell death. In neuroblastoma patients with MYCN-amplified ecDNA, higher frequencies of ecDNA-positive MN at diagnosis are associated with improved event-free and overall survival. Together, these findings link ecDNA mis-segregation to MN formation and reduced cellular fitness, suggesting that ecDNA-positive MN may reflect a state of impaired oncogenic ecDNA function with potential relevance for clinical outcome.